Literature DB >> 10912962

Increased risk of cytomegalovirus transmission in utero during late gestation.

M Bodéus1, C Hubinont, P Goubau.   

Abstract

OBJECTIVE: To determine whether the rate of human cytomegalovirus transmission in utero is related to the gestational age at the time of maternal infection.
METHODS: One hundred twenty-three pregnant women followed in our units between 1988 and 1998 were studied retrospectively. Each had developed a primary infection with cytomegalovirus evidenced by a seroconversion, confirmed by specific enzyme immunoassays. Infants were diagnosed by urine culture.
RESULTS: Regardless of gestational age at the time of maternal cytomegalovirus seroconversion, the mean rate of intrauterine transmission was 57.5%. There was a statistically significant difference between early seroconversion (during the first trimester) and late seroconversion (during the third trimester) (36.0% versus 77.6%; P < .001). The risk of transmission calculated for seroconversion during the second trimester was intermediate (44.9%).
CONCLUSION: A statistically significant difference in the rate of intrauterine cytomegalovirus transmission was observed according to the duration of pregnancy at which primary infection occurred. The rate of transmission increased with gestational age.

Entities:  

Mesh:

Year:  1999        PMID: 10912962

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  16 in total

1.  Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection.

Authors:  S Gouarin; E Gault; A Vabret; D Cointe; F Rozenberg; L Grangeot-Keros; P Barjot; A Garbarg-Chenon; P Lebon; F Freymuth
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

Review 2.  The "silent" global burden of congenital cytomegalovirus.

Authors:  Sheetal Manicklal; Vincent C Emery; Tiziana Lazzarotto; Suresh B Boppana; Ravindra K Gupta
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

3.  Reactivity to p52 and CM2 recombinant proteins in primary human cytomegalovirus infection with a microparticle agglutination assay.

Authors:  E Nulens; M Bodéus; F Bonelli; A Soleti; P Goubau
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

4.  Detection of HCMV DNA in placenta, amniotic fluid and fetuses of seropositive women by nested PCR.

Authors:  Mazyar Ziyaeyan; Abdolvahab Alborzi; Amin Abbasian; Mehdi Kalani; Ali Moravej; Jalil Nasiri; Arash Amiri; Niabeddin Hashemi; Firozeh Sefiddashti
Journal:  Eur J Pediatr       Date:  2006-11-03       Impact factor: 3.183

5.  Prevention of maternal cytomegalovirus infection: current status and future prospects.

Authors:  Jessica L Nyholm; Mark R Schleiss
Journal:  Int J Womens Health       Date:  2010-08-09

6.  Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.

Authors:  M G Revello; C Vauloup-Fellous; L Grangeot-Keros; J van Helden; Y Dickstein; I Lipkin; A Mühlbacher; T Lazzarotto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-01       Impact factor: 3.267

Review 7.  Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment.

Authors:  Concetta Marsico; David W Kimberlin
Journal:  Ital J Pediatr       Date:  2017-04-17       Impact factor: 2.638

8.  Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection.

Authors:  Daniele Lilleri; Anna Kabanova; Maria Grazia Revello; Elena Percivalle; Antonella Sarasini; Emilia Genini; Federica Sallusto; Antonio Lanzavecchia; Davide Corti; Giuseppe Gerna
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

9.  Clinical evaluation of the Roche Elecsys CMV IgG Avidity assay.

Authors:  C Vauloup-Fellous; T Lazzarotto; M G Revello; L Grangeot-Keros
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-02       Impact factor: 3.267

10.  The Placental Response to Guinea Pig Cytomegalovirus Depends Upon the Timing of Maternal Infection.

Authors:  Zachary W Berkebile; Dira S Putri; Juan E Abrahante; Davis M Seelig; Mark R Schleiss; Craig J Bierle
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.